Dawood v. Gamer Advantage LLC

District Court, E.D. California·Decided August 4, 2022·No. 2:22-cv-00562·Unknown

Opinion

----oo0oo---- MAHMOOD DAWOOD, on behalf of No. 2:22-cv-00562 WBS KJN himself and all others similarly situated, Plaintiff, MEMORANDUM AND ORDER RE: DEFENDANT’S MOTION TO DISMISS v. Defendant. ----oo0oo---- Plaintiff Mahmood Dawood brought this putative class action against defendant Gamer Advantage LLC alleging fifteen claims in connection with defendant’s FogAway Anti-Fog Spray (“FogAway”). (Docket No. 1.) Defendant moves to dismiss plaintiff’s complaint for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6). (Docket No. 7.) I. Factual and Procedural Background Defendant formulates, designs, manufactures, advertises, distributes, and sells FogAway across the United States, including in California. (Compl. ¶ 1.) FogAway is supposed to prevent foggy eyeglasses, which have become a more common problem because of the use of face masks during the COVID- 19 pandemic. (Id. ¶ 14.) In approximately the summer of 2021, plaintiff purchased FogAway from a Walmart retail store in Lodi, California. (Id. ¶ 9.) Before purchasing FogAway, plaintiff “reviewed the labeling, packaging, and marketing materials” and saw the claims that FogAway is “Safe For Use.”1 (Id.) Plaintiff understood this to be a representation and warranty by defendant that FogAway is “in fact safe for use.” (Id.) The complaint alleges that FogAway contains unsafe per- and polyfluoroalkyl substances (“PFAS”) which “have been shown to have a number of toxicological effects” and exposure can lead to “cancer, liver damage, decreased fertility, and increased risk of asthma and thyroid disease.” (Id. ¶¶ 2-3.) Based on a study done by the Nicholas School of Environment at Duke University, FogAway allegedly exposes consumers to PFAS at levels higher than the Environmental Protection Agency health advisory limit for safe consumption and contains more PFAS than its competitors. (Id. ¶¶ 4-6, 22.) Defendant allegedly concealed the existence of PFAS in FogAway. (Id. ¶ 40.) Plaintiff claims that if he had known about the PFAS, he would not have purchased, or would not have

1 The court notes that “Safe For Use” is not the complete statement on the advertising and labeling for FogAway, as shown in the photos submitted by plaintiff in his complaint. (Compl. ¶ 19.) The implication of this difference as it relates to defendant’s motion to dismiss is discussed below. purchased on the same terms, FogAway. (Id. ¶ 9.) Plaintiff alleges the following claims against defendant: (1) violation of California’s Unfair Competition Law (“UCL”), Cal. Bus. & Prof. Code § 17200; (2) violation of California’s Consumers Legal Remedies Act (“CLRA”), Cal. Civ. Code § 1750; (3) breach of the implied warranty under the Song- Beverly Act, Cal. Civ. Code § 1790; (4) violation of California’s False Advertising Law, Cal. Bus. & Prof. Code § 17500; (5) fraud; (6) constructive fraud; (7) fraudulent inducement; (8) money had and received; (9) fraudulent concealment or omission; (10) fraudulent misrepresentation; (11) negligent misrepresentation; (12) quasi-contract/unjust enrichment; (13) breach of express warranty; (14) violation of the Magnuson-Moss Warranty Act, 15 U.S.C. §§ 2301, et seq.; and (15) negligent failure to warn. (See Compl.) II. Discussion In his opposition, plaintiff conceded his claims for money had and received and negligent failure to warn. (Pl.’s Opp’n at 23 n.4 (Docket No. 9).) Accordingly, these claims will be dismissed. For the remaining claims, defendant argues that plaintiff’s complaint should be dismissed in its entirety because: (1) the representations made by defendant about FogAway are different from those the complaint alleges; (2) the complaint fails to allege a causal relationship between the cost-of- purchase damages and the alleged health-related dangers of FogAway; (3) the class claims rely on conclusory allegations; and (4) the allegations for the fraud-based claims do not satisfy Federal Rule of Civil Procedure 9(b) (“Rule 9(b)”). (Def.’s Mot. at 2.) The court analyzes each argument below. A. Representations about FogAway The complaint alleges that the advertisements and labeling of FogAway represent the product is “Safe For Use.” (Compl. ¶ 9.) However, plaintiff also submits screenshots and photographs of the following actual representations on the advertisements and labeling, which are: (1) “Safe to apply on all lenses, devices, & screens;” (2) “Safe for use on all lenses and devices;” and (3) “Safe and effective on all lens types even those with anti-reflective or super hydrophobic coating.” (Id. ¶ 19.) “Dismissal is appropriate only in the ‘rare situation’ where the ‘advertisement itself made it impossible for the plaintiff to prove that a reasonable consumer was likely to be deceived.’” Morales v. Unilver U.S., Inc., No. 2:13-cv-2213-WBS, 2014 WL 1389613, at *6 (E.D. Cal. Apr. 9, 2014) (quoting Williams v. Gerber Prods. Co., 552 F.3d 934, 939 (9th Cir. 2008)). This is not that rare situation. How consumers would interpret these representations is a question of fact, and not a question that the court can resolve at this stage. See Zeiger v. WellPet LLC, 304 F. Supp. 3d 837, 852 (N.D. Cal. 2018) (“Plaintiffs have provided an actionable theory why the Products are unsafe and why the labels are misleading; whether plaintiffs can prove their theory is a separate question that I cannot resolve at [the motion to dismiss] stage.”) Accepting the allegations in the complaint as true, the complaint sufficiently alleges that consumers could interpret, and that plaintiff did interpret, these representations to mean that the product was safe for use as it relates to human exposure. (See Compl. ¶ 20); Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). Further, plaintiff’s claims are also based upon defendant’s omissions regarding the existence of PFAS in FogAway, and therefore, consumers could interpret FogAway to be safe because of defendant’s omissions regardless of whether defendant explicitly stated FogAway is safe. (See, e.g., Compl. ¶¶ 9, 39, 41-42, 44-45.) Accordingly, the complaint will not be dismissed based on this argument. B. Damages Defendant argues that the complaint does not allege any “physical harm” or “safety-related damages . . . as a result of” plaintiff purchasing FogAway based on the alleged misrepresentations and/or omissions. (Def.’s Mot. at 5-6.) Plaintiff’s alleged injury is that he “purchased, paid a premium, or otherwise paid more for [FogAway] when [he] otherwise would not have absent [d]efendant’s misrepresentations and/or omissions” –- a purely economic injury. (Compl. ¶ 45.) The complaint also alleges in conclusory terms that the defendant “caused injuries and other damages” but does not provide any supporting factual allegations. (See id. ¶¶ 124, 145, 182, 213.) Pursuant to the economic loss doctrine, “[i]n actions for negligence, a manufacturer’s liability is limited to damages for physical injuries; no recovery is allowed for economic loss alone.” Aas v. Superior Ct., 24 Cal. 4th 627, 724 (2000), superseded by statute

Free access — add to your briefcase to read the full text and ask questions with AI

Dawood v. Gamer Advantage LLC, (E.D. Cal. 2022).

Dawood v. Gamer Advantage LLC (Dawood v. Gamer Advantage LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Puig-Infante
19 F.3d 929 (Fifth Circuit, 1994)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hannibal Pictures, Inc. v. Sonja Productions LLC
432 F. App'x 700 (Ninth Circuit, 2011)
Williams v. Gerber Products Co.
552 F.3d 934 (Ninth Circuit, 2008)
Robinson Helicopter Co., Inc. v. Dana Corp.
102 P.3d 268 (California Supreme Court, 2004)
Aas v. Superior Court
12 P.3d 1125 (California Supreme Court, 2000)
Vess v. Ciba-Geigy Corp. USA
317 F.3d 1097 (Ninth Circuit, 2003)
Zeiger v. Wellpet LLC
304 F. Supp. 3d 837 (N.D. California, 2018)
United States v. Martínez-Benítez
914 F.3d 1 (First Circuit, 2019)
Nucal Foods, Inc. v. Quality Egg LLC
918 F. Supp. 2d 1023 (E.D. California, 2013)